Protective epitopes of the Plasmodium falciparum SERA5 malaria vaccine reside in intrinsically unstructured N-terminal repetitive sequences

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Yagi, Masanori ^a   Bang, Gilles ^b   Tougan, Takahiro ^a   Palacpac, Nirianne M Q ^a   Arisue, Nobuko ^a   Aoshi, Taiki ^c,d   Matsumoto, Yoshitsugu ^e   Ishii, Ken J ^c,d   Egwang, Thomas G ^f   Druilhe, Pierre ^b,g   Horii, Toshihiro ^a  

^a OSAKA UNIVERSITY   (Japan)

^b INSTITUT PASTEUR   (France)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f Med Biotech Laboratories Uganda   (Uganda)

^g Vac4all Initiative   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; APICAL MEMBRANE ANTIGEN 1; EPITOPE; MALARIA VACCINE; OCTAMER TRANSCRIPTION FACTOR; SERINE REPEAT ANTIGEN 5; UNCLASSIFIED DRUG;

ADULT; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFICACY; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; IN VITRO STUDY; MALARIA FALCIPARUM; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; SQUIRREL MONKEY; SYMPTOMATOLOGY; UGANDA; VACCINATION; ADOLESCENT; ANIMAL; CHEMISTRY; CHILD; IMMUNOLOGY; MALARIA, FALCIPARUM; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; CHILD; EPITOPES; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; SAIMIRI; YOUNG ADULT;

EID: 84902323912     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098460     Document Type: Article

References (43)

1. WHO World malaria report 2012.
2. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, et al. (2012) Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379: 413-431.
3. Chauhan VS, Yazdani SS, Gaur D (2010) Malaria vaccine development based on merozoite surface proteins of Plasmodium falciparum. Hum Vaccin 6(9): 757-762.
4. Healer J, Murphy V, Hodder AN, Masciantonio R, Gemmill AW, et al. (2004) Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum . Mol Microbiol 52(1): 159-168. (Pubitemid 38519629)
5. Horii T, Shirai H, Jie L, Ishii KJ, Palacpac NMQ, et al. (2010) Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36. Parasitol Int 59(3): 380-386.
6. Palacpac NMQ, Ntege E, Yeka A, Balikagala B, Suzuki N, et al. (2013) Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36. PLoS ONE 8(5), e64073.
7. Palacpac NMQ, Arisue N, Tougan T, Ishii KJ, Horii T (2011) Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate. Vaccine 29(35): 5837-5845.
8. Li J, Mitamura T, Fox BA, Bzik DJ, Horii T (2002) Differential localization of processed fragments of Plasmodium falciparum serine repeat antigen and further processing of its N-terminal 47 kDa fragment. Parasitol Int 51(4): 343-352. (Pubitemid 35287506)
9. Aoki S, Li J, Itagaki S, Okech BA, Egwang TG, et al. (2002) Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth. J Biol Chem 277(49): 47533-47540. (Pubitemid 36159272)
10. Yeoh S, O'Donnell RA, Koussis K, Dluzewski AR, Ansell KH, et al. (2007) Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes. Cell 131(6): 1072-1083. (Pubitemid 350235024)
11. Tanabe K, Arisue N, Palacpac NM, Yagi M, Tougan T, et al. (2012) Geographic differentiation of polymorphism in the Plasmodium falciparum malaria vaccine candidate gene SERA5. Vaccine 30(9): 1583-1593.
12. Okech BA, Nalunkuma A, Okello D, Pang XL, Suzue K, et al. (2001) Natural human immunoglobulin G subclass responses to Plasmodium falciparum serine repeat antigen in Uganda. Am J Trop Med Hyg 65(6): 912-917. (Pubitemid 34049496)
13. Okech B, Mujuzi G, Ogwal A, Shirai H, Horii T, et al. (2006) High titers of IgG antibodies against Plasmodium falciparum serine repeat antigen 5 (SERA5) are associated with protection against severe malaria in Ugandan children. Am J Trop Med Hyg 74(2): 191-197. (Pubitemid 46774326)
14. Pang XL, Mitamura T, Horii T (1999) Antibodies reactive with the N-terminal domain of Plasmodium falciparum serine repeat antigen inhibit cell proliferation by agglutinating merozoites and schizonts. Infect Immun 67(4): 1821-1827. (Pubitemid 29144402)
15. Pang XL, Horii T (1998) Complement-mediated killing of Plasmodium falciparum erythrocytic schizont with antibodies to the recombinant serine repeat antigen (SERA). Vaccine 16(13): 1299-1305.
16. Soe S, Singh S, Camus D, Horii T, Druilhe P (2002) Plasmodium falciparum serine repeat protein, a new target of monocyte-dependent antibody-mediated parasite killing. Infect Immun 70(12): 7182-7184. (Pubitemid 35390401)
17. Fox BA, Pang XL, Suzue K, Horii T, Bzik DJ (1997) Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies. Exp Parasitol 85(2): 121-134. (Pubitemid 27247973)
18. Fox BA, Horii T, Bzik DJ (2002) Plasmodium falciparum: fine-mapping of an epitope of the serine repeat antigen that is a target of parasite-inhibitory antibodies. Exp Parasitol 101(1): 69-72. (Pubitemid 36279305)
19. Uversky VN (2011) Intrinsically disordered proteins from A to Z. Int J Biochem Cell Biol 43(8): 1090-1103.
20. Tompa P (2012) Intrinsically disordered proteins: a 10-year recap. Trends Biochem Sci 37(12): 509-516.
21. Zilversmit MM, Volkman SK, DePristo MA, Wirth DF, Awadalla P, et al. (2010) Low-complexity regions in Plasmodium falciparum: missing links in the evolution of an extreme genome. Mol Biol Evol 27(9): 2198-2209.
22. Mohan A, Sullivan WJ Jr, Radivojac P, Dunker AK, Uversky VN (2008) Intrinsic disorder in pathogenic and non-pathogenic microbes: discovering and analyzing the unfoldomes of early-branching eukaryotes. Mol Biosyst 4(4): 328-340. (Pubitemid 351422588)
23. Zhang X, Perugini MA, Yao S, Adda CG, Murphy VJ, et al. (2008) Solution conformation, backbone dynamics and lipid interactions of the intrinsically unstructured malaria surface protein MSP2. J Mol Biol 379(1): 105-121.
24. Olugbile S, Kulangara C, Bang G, Bertholet S, Suzarte E, et al. (2009) Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165c. Infect Immun 77(12): 5701-5709.
25. Kulangara C, Luedin S, Dietz O, Rusch S, Frank G, et al. (2012) Cell biological characterization of the malaria vaccine candidate trophozoite exported protein 1. PLoS One. 7(10): e46112.
26. Bueno LL, Lobo FP, Morais CG, Mourão LC, de Ávila RA, et al. (2011) Identification of a highly antigenic linear B cell epitope within Plasmodium vivax apical membrane antigen 1 (AMA-1). PLoS One. 6(6): e21289.
27. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P (1990) Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 172(6): 1633-1641.
28. Jafarshad A, Dziegiel MH, Lundquist R, Nielsen LK, Singh S, et al. (2007) A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes Fc cRII and FccRIII. J Immunol 178(5): 3099-3106. (Pubitemid 46333191)
29. Druilhe P, Spertini F, Soesoe D, Corradin G, Mejia P, et al. (2005) A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum. PLoS Med 2(11): e344.
30. Kim OTP, Yura K, Go N (2006) Amino acid residue doublet propensity in the protein-RNA interface and its application to RNA interface prediction. Nucleic Acids Res 34(22): 6450-6460. (Pubitemid 46017942)
31. Emanuelsson O, Brunak S, von Heijne G, Nielsen H (2007) Locating proteins in the cell using TargetP, SignalP, and related tools. Nat Protoc 2(4): 953-971. (Pubitemid 46745592)
32. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22(22): 4673-4680. (Pubitemid 24354800)
33. Combet C, Blanchet C, Geourjon C, Deléage G (2000) NPS@: network protein sequence analysis. Trends Biochem Sci 25(3): 147-150. (Pubitemid 30122428)
34. Igarashi Y, Heureux E, Doctor KS, Talwar P, Gramatikova S, et al. (2009) PMAP: databases for analyzing proteolytic events and pathways. Nucleic Acids Res 37:D611-618.
35. Gill SC, von Hippel PH (1989) Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem 182(2): 319-326. (Pubitemid 19277112)
36. Sabchareon A, Burnouf T, Ouattara D, Attanath P, Bouharoun-Tayoun H, et al. (1991) Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg 45(3): 297-308.
37. Bouharoun-Tayoun H, Oeuvray C, Lunel F, Druilhe P (1995) Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med 182(2): 409-418.
38. Liu J, Perumal NB, Oldfield CJ, Su EW, Uversky VN, et al. (2006) Intrinsic disorder in transcription factors. Biochemistry 45(22): 6873-6888. (Pubitemid 43856673)
39. Hilser VJ, Thompson EB (2011) Structural dynamics, intrinsic disorder, and allostery in nuclear receptors as transcription factors. J Biol Chem 286(46): 39675-39682.
40. Shoemaker BA, Portman JJ, Wolynes PG (2000) Speeding molecular recognition by using the folding funnel: the fly-casting mechanism. Proc Natl Acad Sci U S A 97(16): 8868-8873. (Pubitemid 30626639)
41. Levy Y, Onuchic JN, Wolynes PG (2007) Fly-casting in protein-DNA binding: frustration between protein folding and electrostatics facilitates target recognition. J Am Chem Soc 129(4): 738-739. (Pubitemid 46183905)
42. Adda CG, MacRaild CA, Reiling L, Wycherley K, Boyle MJ, et al. (2012) Antigenic characterization of an intrinsically unstructured protein, Plasmodium falciparum merozoite surface protein 2. Infect Immun 80(12): 4177-4185.
43. Pan W, Huang D, Zhang Q, Qu L, Zhang D, et al. (2004) Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro. J Immunol 172(10): 6167-6174. (Pubitemid 38621222)